Clinical Trials
7
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Conditions
- Major Depressive Disorder (MDD)Depression in AdultsDepression - Major Depressive DisorderDepression DisordersDepression DisorderDepression
- Interventions
- Behavioral: Psychological Support
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 330
- Registration Number
- NCT06793397
- Locations
- 🇺🇸
UAB Psychiatry and Behavioral Neurology, Birmingham, Alabama, United States
🇺🇸Pillar Clinical Research - Little Rock, Little Rock, Arkansas, United States
🇺🇸Behavioral Research Specialists, LLC, Glendale, California, United States
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2025-10-31
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 468
- Registration Number
- NCT06605105
- Locations
- 🇺🇸
Adams Clinical, Watertown, Massachusetts, United States
🇺🇸InSite Clinical Research, LLC, DeSoto, Texas, United States
🇺🇸Research Centers of America, Hollywood, Florida, United States
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 220
- Registration Number
- NCT06564818
- Locations
- 🇺🇸
Scottsdale Research Institute, Phoenix, Arizona, United States
🇺🇸Noble Clinical Research, Tucson, Arizona, United States
🇺🇸Del Sol Research Management, Tucson, Arizona, United States
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Behavioral: Psychotherapy
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2025-10-27
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 36
- Registration Number
- NCT06051721
- Locations
- 🇺🇸
Research Centers of America, Hollywood, Florida, United States
🇺🇸Uptown Research Institute, Chicago, Illinois, United States
🇺🇸Innovative Clinical Research, Inc., Miami Lakes, Florida, United States
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2022-05-23
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Cybin IRL Limited
- Target Recruit Count
- 57
- Registration Number
- NCT05385783
- Locations
- 🇺🇸
CenExel ACMR, Atlanta, Georgia, United States
🇺🇸iResearch Atlanta, Decatur, Georgia, United States
🇺🇸Clinilabs Drug Development Corporation, Eatontown, New Jersey, United States